Investigation of the effect of the Egualen Sodium Hydrate mouthwash on the stomatitis induced by the gastroenterological cancer chemotherapy

Investigation of the effect of the Egualen Sodium Hydrate mouthwash on the stomatitis induced by the gastroenterological cancer chemotherapy - Investigation of the effect of the Egualen Sodium Hydrate mouthwash on the stomatitis induced by the gastroenterological cancer chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005599

Enrollment

Registered

2011-06-01

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stomatitis

Interventions

To rinse using Egualen sodium hydrate mouthwash (0.6g/time and 4 times/day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients of the stomatitis induced by gastroenterological cancer chemotherapy 2) Age more than 20 years old 3) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who have a difficulty to rinse their mouths 2) Patients who rinse other mouthwash except for Povidone-iodine gargle 3) Pregnant women

Design outcomes

Primary

Measure	Time frame
The efficacy of the improvement for the stomatitis	—

Countries

Japan

Contacts

Public ContactHiroshi Miyamoto

Tokushima University Hospital Department of Gastroenterology

miyamoto.hiroshi@tokushima-u.ac.jp088-633-7124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026